UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 43 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $393,000 | +110.2% | 994,787 | +200.4% | 0.00% | – |
| Q2 2022 | $187,000 | -77.8% | 331,123 | -56.0% | 0.00% | – |
| Q1 2022 | $842,000 | +4.5% | 752,163 | +36.3% | 0.00% | – |
| Q4 2021 | $806,000 | -38.8% | 551,908 | +25.6% | 0.00% | -100.0% |
| Q3 2021 | $1,318,000 | -53.1% | 439,306 | -27.5% | 0.00% | -50.0% |
| Q2 2021 | $2,812,000 | -39.1% | 606,041 | +13.9% | 0.00% | -66.7% |
| Q2 2020 | $4,618,000 | +2494.4% | 532,047 | +1629.4% | 0.01% | – |
| Q1 2020 | $178,000 | -93.8% | 30,765 | -92.3% | 0.00% | -100.0% |
| Q4 2019 | $2,879,000 | +122.0% | 399,337 | +87.8% | 0.00% | +100.0% |
| Q3 2019 | $1,297,000 | +393.2% | 212,666 | +667.5% | 0.00% | – |
| Q2 2019 | $263,000 | -62.0% | 27,708 | -67.6% | 0.00% | -100.0% |
| Q1 2019 | $693,000 | +4.1% | 85,422 | +108.9% | 0.00% | 0.0% |
| Q3 2018 | $666,000 | – | 40,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |